Bank of America
RXII

Bank of America’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bank of America’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-49,800
Closed -$75K – 8138
2014
Q4 		$75K Sell
49,800
-39,400
-44% -$59.3K ﹤0.01% 6095
2014
Q3 		$184K Sell
89,200
-32,400
-27% -$66.8K ﹤0.01% 5459
2014
Q2 		$372K Sell
121,600
-392,100
-76% -$1.2M ﹤0.01% 4913
2014
Q1 		$1.28M Buy
513,700
+149,800
+41% +$374K ﹤0.01% 3647
2013
Q4 		$1.8M Buy
363,900
+13,900
+4% +$68.9K ﹤0.01% 3415
2013
Q3 		$798K Buy
+350,000
New +$798K ﹤0.01% 4178

Bank of America's RXII Position: Q4 2016 in Review

Bank of America sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 9,839 shares — an estimated $4K sold.

Bank of America first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $723K in Q2 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Bank of America reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Bank of America sold 9,839 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $4K.
  • Bank of America first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
  • Bank of America's GALENA BIOPHARMA INC COM position peaked at $723K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.